Abstract
The increased appreciation of nitric oxide (NO) as an important molecule in biology and medicine has been accompanied by an unprecedented interest in inhibitors of NO synthesis and NO scavengers. l-Arginine analogues (Fig. 1) have been used widely as competitive inhibitors of NO synthase (NOS), thus inhibiting the function of NO indirectly. Some of these analogues have even been used in human trials, although there are potential problems with in vivo use. l-Arginine analogues may interfere with the urea cycle and protein synthesis, and long-term suppression of both the constitutive (cNOS) and the induced forms (NOS) of the enzyme might result in impairment of the neural and circulatory systems. Although l-arginine analogues can suppress the biological effect of endothelium-derived relaxing factor (EDRF) stimulators, such as acetylcholine, proof that NO is an EDRF awaits the demonstration of chemical entrapment of NO at the site of action with simultaneous disappearance of its vasorelaxing activity. Meanwhile NO gas or dilute NO solutions have been shown to relax vascular tone, and the identity of EDRF with NO appears essentially unambiguous.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Akaike T, Yoshida M, Miyamoto Y, Sato K, Kohno M, Sasamoto K, Miyazaki K, Ueda S, Maeda H (1993) Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/. NO through a radical reaction. Biochemistry 32: 827–832
Bredt DS. Snyder SH (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682–685
Drapier JC (1991) L-Arginine-derived nitric oxide and the cell mediated immune response. Res Immune) 142: 551–602
Ettinghausen SE, Puri RJ, Rosenberg SA (1988) Increased vascular permeability in organs mediated by the systematic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. J Natl Cancer Inst, 80: 177–187
Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4–6
Gatley SJ, Sherratt HSA (1976) The effects of diphenyleneiodonium on mitochondrial reactions: Relation of binding of diphenylene 1257 iodonium to mitochondria to the extent of inhibition of oxygen uptake. Biochem J 158: 307–315
Gross SS, Levi R (1992) Tetrahydrobiopterin synthesis: an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267: 25722–25729
Hibbs JB Jr, Taintor RR, Vartin Z (1987) Macrophage cytotoxicity: role for L-arginine deiminase and iminonitrogen oxidation to nitrite. Science 235: 473–476
Iwai K, Maeda H, Konno T (1984) Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res 44: 2114–2121
Kanner J, Harel S, Granit R (1992) Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 27: 46–49
Kelm M, Feelisch M, Spahr R, Pipper M, Noack E, Schrader J (1988) Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem Biophys Res Commun 154: 236–244
Kilbourn RG, Griffith OW (1992) Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84: 827–831
Maeda H, Matsumura Y (1989) Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 6: 193–210
Maeda H (1991) SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev 6: 181–202
Maeda H, Matsumura Y, Kato H (1988) Purification and identification of [hydroxyprolyl3]-bradykinin in ascitic fluid from a patient with gastric cancer. J Biol Chem 263: 16051–16056
Maeda H, Seymour LW, Miyamoto Y (1992) Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconj Chem 3: 351–362
Maeda H, Noguchi Y, Sato K, Akaike T (1994) Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 85: 331–334
Matsumura Y, Maeda H (1986) A new concept of macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and anti tumor agent SMANCS. Cancer Res 46: 6387–6392
Matsumura Y, Kimura M, Yamamoto T, Maeda H (1988) Involvement of kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn J Cancer Res 79: 1327–1334
Matsumura Y, Maruo K, Kimura M, Yamamoto T, Konno T, Maeda H (1991) Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn J Cancer Res 82: 732–741
Moncada S, Palmer RMJ, Higgs EA (1992) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142
Myers PR, Guerra R Jr, Harrison DG (1992) Release of multiple endothelium-derived relaxing factors from porcine coronary arteries. J Cardiovasc Pharmacol. 20: 392–400
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526
Ribieiro JMC, Hazzard JMH, Nussenzveig RH, Champagene DE, Walker FA (1993) Reversible binding of nitric oxide by a salivary heme protein from a bloodsucking insect. Science 260: 539–541
Sakai N, Kaufman S, Milstien S (1993) Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol Pharmacol 43: 6–10
Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascitic fluid. Science 219: 983–985
Skinner SA, Tutton PJM, O’Brein E (1990) Microvasculature architecture of experimental colon tumor in rats. Cancer Res 50: 2411–2417
Stamler JS, Jaraki 0, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89: 7674–7677
Stuehr DJ, Nathan CF (1991) Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543–1555
Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzales JA, Levi R, Nathan CF (1991) Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5: 98–103
Suzuki M, Takahashi T, Sato T (1987) Medial regression and its functional significance in tumor supplying host arteries. Cancer 59: 444–450
Tadjkarimi S, O’Neil GS, Luu TN, Allen SP, Schyns CJ, Chester AH, Yacoub MH (1992) Comparison of cyclic GMP in human internal mammary artery and saphenous vein: implications for coronary artery bypass graft patency; Cardiovasc Res 26: 297–300
Yoshida K, Akaike T, Doi T, Sato K, Ijiri S, Suga M, Ando M, Maeda H (1993) Pronounces enhancement of NO-dependent antimicrobial action by an NO-oxidizing agent, imidazolineoxyl N-oxide. Infect Immun 61: 3552–3555
Yoshida M, Akaike T, Wada Y, Sato K, Ikeda K, Ueda S, Maeda H (1994) Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 202: 930–932
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Maeda, H., Akaike, T., Yoshida, M., Sato, K., Noguchi, Y. (1995). A New Nitric Oxide Scavenger, Imidazolineoxyl N-Oxide Derivative, and Its Effects in Pathophysiology and Microbiology. In: Koprowski, H., Maeda, H. (eds) The Role of Nitric Oxide in Physiology and Pathophysiology. Current Topics in Microbiology and Immunology, vol 196. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79130-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-79130-7_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79132-1
Online ISBN: 978-3-642-79130-7
eBook Packages: Springer Book Archive